The Flowr Corporation (FLWPF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.18: the stock has moved about 18% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerThe Flowr Corporation (FLWPF) trades at $0.00001. The Flowr Corporation cultivates, produces, and sells cannabis products, primarily dried flowers and pre-rolls, across Canada, Portugal, and the European Union. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for FLWPF: FLWPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
The Flowr Corporation (FLWPF) Healthcare & Pipeline Overview
The Flowr Corporation is a Canadian-headquartered cannabis company specializing in the cultivation, production, and sale of dried flowers and pre-rolls. With operations spanning Canada, Portugal, and the European Union, it navigates the evolving global cannabis market, focusing on product delivery in regulated environments.
What Is the Investment Thesis for FLWPF?
The Flowr Corporation's investment thesis centers on its strategic positioning within the expanding global cannabis market, particularly its dual presence in the established Canadian market and the emerging European Union. The company's focus on dried flowers and pre-rolls represents a core segment of cannabis consumption. While current financial metrics indicate challenges, such as a Gross Margin of -60.2% and a Return on Equity (ROE) of -158.8%, potential value drivers include the maturation of the European medical cannabis market and the company's ability to leverage its Portuguese operations as an export hub. A Beta of 1.18 suggests higher volatility relative to the market, which is common in emerging industries. Future growth catalysts could include regulatory advancements in key European markets, successful product diversification beyond current offerings, and operational efficiencies improving the negative gross margin. The company's Debt-to-Equity ratio of 72.63 indicates a reliance on debt financing, which requires careful monitoring. Realizing value will depend on the company's capacity to scale operations profitably and capture market share in a highly competitive and regulated environment.
Based on FMP financials and quantitative analysis
FLWPF Key Highlights
Market Capitalization stands at $0.00B, reflecting a relatively small market valuation.
- Gross Margin is reported at -60.2%, indicating that the cost of goods sold significantly exceeds revenue.
- Return on Equity (ROE) is -158.8%, suggesting substantial losses relative to shareholder equity.
- Debt-to-Equity ratio is 72.63, indicating a notable reliance on debt financing for its operations.
- Free Cash Flow (FCF) is -$0.00B, signifying negative cash generation from operations after capital expenditures.
Who Are FLWPF's Competitors?
FLWPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FLWPF's Key Strengths?
Established operations in both Canadian and European markets.
- Focus on core cannabis products like dried flowers and pre-rolls.
- Experience in navigating complex cannabis regulatory environments.
- Headquartered in Canada, a leading country in cannabis legalization.
What Are FLWPF's Weaknesses?
Negative Gross Margin of -60.2% indicates significant operational inefficiencies.
- Negative Return on Equity of -158.8% points to substantial unprofitability.
- Market Capitalization of $0.00B suggests limited financial scale and investor confidence.
- Reliance on debt financing with a D/E ratio of 72.63.
What Are the Key Risks for FLWPF?
Financial-distress signal — its Altman Z-Score of -16.36 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
- Significant operational inefficiencies, as evidenced by a -60.2% Gross Margin, pose a substantial risk to profitability and long-term viability.
- Intense competition within the fragmented global cannabis market could lead to pricing pressures and difficulty in gaining or maintaining market share.
- The evolving and often unpredictable regulatory landscape for cannabis across Canada and the EU presents ongoing compliance challenges and potential for market disruption.
- Limited access to capital and challenges in securing additional financing, especially given negative financial performance, could hinder growth initiatives and operational stability.
- Low liquidity and unknown disclosure status on the OTC market expose investors to higher trading risks and limited access to critical company information.
What Threats Does FLWPF Face?
- Intense competition from numerous licensed producers in all operating markets.
- Evolving and potentially restrictive regulatory changes in cannabis markets.
- Black market competition impacting legal sales and pricing.
- Capital constraints and difficulty in securing financing given current financial performance.
What Are FLWPF's Competitive Advantages?
- Established cultivation and processing infrastructure in Canada and Portugal.
- Access to the European Union market through Portuguese operations, potentially leveraging EU-GMP certification.
- Brand recognition and consumer loyalty within specific product categories in its operating markets.
- Experience in navigating complex and evolving cannabis regulatory frameworks across multiple jurisdictions.
What Does FLWPF Do?
The Flowr Corporation, incorporated in 2016 and headquartered in Toronto, Canada, operates as a cultivator, producer, and seller of cannabis products. The company's core offerings include dried flowers and pre-rolls, catering to various segments of the cannabis market. From its inception, Flowr has focused on establishing a presence within the burgeoning legal cannabis industry, initially concentrating on the Canadian market. Over its operational history, the company has strategically expanded its geographic footprint beyond Canada, establishing operations in Portugal and extending its reach into the broader European Union. This international expansion reflects a strategic effort to tap into diverse regulatory frameworks and emerging market opportunities for cannabis. The company's business model is centered on the controlled cultivation of cannabis, followed by processing and distribution of its branded products. This integrated approach aims to maintain quality control from seed to sale. Operating within the 'Drug Manufacturers - Specialty & Generic' industry, Flowr positions itself among companies involved in the production of specialized pharmaceutical or therapeutic products, albeit with a focus on cannabis. Its competitive positioning is influenced by factors such as product quality, brand recognition, cultivation efficiency, and the ability to navigate complex and evolving regulatory landscapes across its operational territories.
What Products and Services Does FLWPF Offer?
- Cultivates cannabis plants in controlled environments.
- Produces dried cannabis flowers for various markets.
- Manufactures pre-rolled cannabis products.
- Sells cannabis products in the Canadian market.
- Operates cultivation and production facilities in Portugal.
- Distributes cannabis products to the European Union.
- Focuses on the specialty and generic drug manufacturing sector with cannabis products.
How Does FLWPF Make Money?
- Cultivation-to-Sale: Integrated model covering the entire value chain from growing cannabis to processing and selling finished products.
- Product Specialization: Focus on core cannabis formats like dried flowers and pre-rolls.
- Geographic Diversification: Revenue generation from both the Canadian recreational market and the European medical market.
- Regulatory Compliance: Adherence to strict cannabis regulations in each operating jurisdiction to ensure legal market access.
What Industry Does FLWPF Operate In?
The Flowr Corporation operates within the dynamic and rapidly evolving global cannabis industry, specifically categorized under 'Drug Manufacturers - Specialty & Generic' due to the therapeutic applications of cannabis. This sector is characterized by significant regulatory complexities, varying legal statuses across jurisdictions, and intense competition. Globally, the cannabis market is experiencing substantial growth, driven by increasing legalization for medical and recreational use, particularly in North America and Europe. Flowr's presence in Canada, a mature recreational market, and the European Union, primarily an emerging medical market, positions it to capitalize on different growth trajectories. Key market trends include a shift towards higher-quality products, product diversification into edibles, concentrates, and topicals, and the consolidation of smaller players. Flowr competes with numerous licensed producers, both large-scale and niche, striving to differentiate through cultivation practices, brand reputation, and market access. The company's ability to navigate these trends and regulatory shifts will be crucial for its market positioning.
Who Are FLWPF's Key Customers?
- Licensed provincial and territorial distributors in Canada for recreational sales.
- Medical cannabis patients in the European Union through authorized channels.
- Wholesale partners and pharmacies in European markets.
- Adult-use consumers in Canadian retail stores.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Forward Outlook
Wall Street analysts project The Flowr Corporation revenue of about $46.9M for fiscal 2026, with EPS near $0.00.
Key Financial Metrics
Return on assets is -16.4%, showing how much profit it generates from its asset base. A current ratio of 1.40 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
The Flowr Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -16.36 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
The Flowr Corporation has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 154.6% below estimates on average.
Company Profile
The Flowr Corporation operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Steven Adam Klein. FLWPF has traded publicly since 2021.
FLWPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
FLWPF Latest News
-
Avant Brands Completes EU GMP Audit at Flowr Facility
Yahoo! Finance: FLWPF News · Aug 20, 2026
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
FLWPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FLWPF.
Price Targets
Wall Street price target analysis for FLWPF.
FLWPF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FLWPF; grades run from A+ (80-100) to F (below 30).
Latest News
Avant Brands Completes EU GMP Audit at Flowr Facility
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Stocks That Hit 52-Week Highs On Tuesday
Leadership: Steven Adam Klein
Chief Executive Officer
Steven Adam Klein serves as the Chief Executive Officer of The Flowr Corporation. His career has been marked by strategic leadership roles, particularly within sectors characterized by rapid growth and complex regulatory landscapes. Mr. Klein brings experience in corporate development, operational scaling, and market entry strategies. His professional journey has involved navigating the intricacies of emerging industries and building robust organizational structures to support expansion and compliance. He is recognized for his ability to guide companies through challenging market conditions while pursuing growth objectives.
Track Record: Under Mr. Klein's leadership, The Flowr Corporation has focused on optimizing its cultivation and production processes in Canada and expanding its footprint into international markets, notably Portugal and the European Union. His strategic initiatives have aimed at enhancing product quality, improving operational efficiencies, and securing market access in evolving global cannabis landscapes. Mr. Klein has been instrumental in steering the company's efforts to adapt to changing consumer demands and regulatory environments.
FLWPF OTC Market Information
The Flowr Corporation trades on the OTC Other tier of the OTC Markets. This tier is typically for companies that do not meet the disclosure requirements of higher tiers like OTCQX or OTCQB, or for those that choose not to provide extensive public information. Unlike stocks listed on major exchanges such as the NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and disclosure, companies on the OTC Other tier have minimal or unknown disclosure obligations. This can result in less transparency for investors compared to exchange-listed securities.
- OTC Tier: OTC Other
- Limited Transparency: Unknown disclosure status means investors have limited access to financial statements and operational updates, increasing informational asymmetry.
- Low Liquidity: Thin trading volumes can make it difficult to buy or sell shares without significant price impact, potentially leading to substantial losses.
- Price Volatility: Shares on the OTC Other tier are often subject to extreme price fluctuations due due to low trading volume and limited public information.
- Lack of Analyst Coverage: Minimal or no analyst coverage means less independent research and scrutiny, leaving investors to rely solely on limited public data.
- Potential for Manipulation: Lower regulatory oversight and transparency can make OTC stocks more susceptible to market manipulation schemes.
- Verify the company's most recent financial statements and audit reports, if available.
- Research any news releases or corporate filings made with Canadian regulators (e.g., SEDAR).
- Assess the company's operational status and any recent business developments through independent sources.
- Investigate the background and track record of management beyond what is publicly stated.
- Understand the current regulatory environment for cannabis in Canada and the EU and its impact on the company.
- Evaluate the company's cash burn rate and access to capital given its negative FCF and gross margin.
- Consult with a financial advisor experienced in microcap or OTC investments.
- Incorporated in 2016, indicating a history of operations.
- Headquartered in Toronto, Canada, a well-regulated financial hub.
- Stated operations in Canada, Portugal, and the European Union, suggesting international business activity.
- Publicly traded, albeit on OTC markets, which provides some level of market access.
What Investors Ask About The Flowr Corporation (FLWPF) — Healthcare
What does The Flowr Corporation do?
The Flowr Corporation is a Canadian-headquartered company primarily engaged in the cultivation, production, and sale of cannabis. Its main product offerings include dried cannabis flowers and pre-rolls.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Growth opportunities are derived from the company's stated operations and general industry trends, not explicit company announcements of future projects.